Literature DB >> 26502816

Lipid-Based Diets Improve Muscarinic Neurotransmission in the Hippocampus of Transgenic APPswe/PS1dE9 Mice.

Helena Janickova, Vladimir Rudajev, Eva Dolejsi, Hennariikka Koivisto, Jan Jakubik, Heikki Tanila, Esam E El-Fakahany, Vladimir Dolezal1.   

Abstract

Transgenic APPswe/PS1dE9 mice modeling Alzheimer's disease demonstrate ongoing accumulation of β-amyloid fragments resulting in formation of amyloid plaques that starts at the age of 4-5 months. Buildup of β-amyloid fragments is accompanied by impairment of muscarinic transmission that becomes detectable at this age, well before the appearance of cognitive deficits that manifest around the age of 12 months. We have recently demonstrated that long-term feeding of trangenic mice with specific isocaloric fish oil-based diets improves specific behavioral parameters. Now we report on the influence of short-term feeding (3 weeks) of three isocaloric diets supplemented with Fortasyn (containing fish oil and ingredients supporting membrane renewal), the plant sterol stigmasterol together with fish oil, and stigmasterol alone on markers of cholinergic neurotransmission in the hippocampus of 5-month-old transgenic mice and their wild-type littermates. Transgenic mice fed normal diet demostrated increase in ChAT activity and attenuation of carbachol-stimulated GTP-γ(35)S binding compared to wild-type mice. None of the tested diets compared to control diet influenced the activities of ChAT, AChE, BuChE, muscarinic receptor density or carbachol-stimulated GTP-γ(35)S binding in wild-type mice. In contrast, all experimental diets increased the potency of carbachol in stimulating GTP-γ(35)S binding in trangenic mice to the level found in wild-type animals. Only the Fortasyn diet increased markers of cholinergic synapses in transgenic mice. Our data demonstrate that even short-term feeding of transgenic mice with chow containing specific lipid-based dietary supplements can influence markers of cholinergic synapses and rectify impaired muscarinic signal transduction that develops in transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26502816     DOI: 10.2174/1567205012666151027130350

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  8 in total

Review 1.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

Review 2.  Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review.

Authors:  Barry S Baumel; P Murali Doraiswamy; Marwan Sabbagh; Richard Wurtman
Journal:  Neurol Ther       Date:  2020-12-26

3.  Magnetoencephalography for the Detection of Intervention Effects of a Specific Nutrient Combination in Patients with Mild Alzheimer's Disease: Results from an Exploratory Double-Blind, Randomized, Controlled Study.

Authors:  Elisabeth C W van Straaten; Hanneke de Waal; Marieke M Lansbergen; Philip Scheltens; Fernando Maestu; Rafal Nowak; Arjan Hillebrand; Cornelis J Stam
Journal:  Front Neurol       Date:  2016-10-17       Impact factor: 4.003

4.  Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease.

Authors:  Paula Perez-Pardo; Esther M de Jong; Laus M Broersen; Nick van Wijk; Amos Attali; Johan Garssen; Aletta D Kraneveld
Journal:  Front Aging Neurosci       Date:  2017-03-20       Impact factor: 5.750

5.  24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.

Authors:  Hilkka Soininen; Alina Solomon; Pieter Jelle Visser; Suzanne B Hendrix; Kaj Blennow; Miia Kivipelto; Tobias Hartmann
Journal:  Lancet Neurol       Date:  2017-10-30       Impact factor: 44.182

6.  Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease.

Authors:  Nienke M E Scheltens; Ingrid S Kuyper; Ronald Boellaard; Frederik Barkhof; Charlotte E Teunissen; Laus M Broersen; Marieke M Lansbergen; Wiesje M van der Flier; Bart N M van Berckel; Philip Scheltens
Journal:  Alzheimers Dement (N Y)       Date:  2016-09-01

7.  The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease?

Authors:  Jill Rasmussen
Journal:  Clin Interv Aging       Date:  2019-08-15       Impact factor: 4.458

Review 8.  Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer's disease.

Authors:  Vladimir Rudajev; Jiri Novotny
Journal:  Front Mol Neurosci       Date:  2022-08-25       Impact factor: 6.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.